Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2175672Generated: October 29, 2026

Dimethyl Sulfoxide → Artesunate

https://huagongshe.com/reaction/2175672

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDimethyl SulfoxideHCID 679—
ReactantSodium BicarbonateHCID 516892—
ReactantArtesunateHCID 6917864—
CatalystCarbon monooxide--dichlororuthenium (3/1)HCID 10951331—
ProductArtesunateHCID 6917864—
ProductSodium;4-oxo-4-[[(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoateHCID 23697153—

Reaction Steps

CORM-2 (Sigma-Aldrich) and Compound 2 were solubilized using 10% dimethyl sulfoxide (DMSO; Sigma-Aldrich) in PBS. CORM-3 and Compound 1 were solubilized in PBS (1×). CORM-2 solution (20 mg/kg of body weight) was administered intravenously (i.v.) according to the chosen schedules. Compound 2, CORM-3 and Compound 1 were administered i.v. at equimolar concentrations relative to CORM-2 (36.7 mg/Kg). As vehicle control, we used a solution of 10% DMSO in PBS administered i.v. The concentrations of CORM-2 used in the present study were based on previous reports (see, e.g., Chen et al. Am. J. Pathol. (2009) 175:422-429; Sun et al., World. J. Gastroenterol. (2008) 14:547-553). Artesunate is presented as a powder of artesunic acid. Artesunate (AS) solution was prepared by dissolving 60 mg of anhydrous artesunic acid in 1 ml of sodium bicarbonate (5%) to form sodium artesunate and then diluted in 5 ml of NaCl (0.9%). An AS solution (i.p.) was administered at 40 mg/Kg/day, as described previously (see, e.g., Bienvenu, Acta Trop (2008) 106:104-108). The AS treatment was started when the infected non-treated mice presented the clinical stage 1 for experimental cerebral malaria.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09062089B2
Source datasetuspto-grants-2015_06
ORD IDord-40e8dc03b0da4e088a57305f09857ed8
Source noteuspto-grants-2015_06